XML 74 R79.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation and Equity - Summary of Incentive Unit Activity (Detail) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted average exercise price per share, granted (in dollars per share) $ 1.95    
313 Acquisition LLC | Incentive Units      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding, Beginning Balance (shares) 85,362,836.000 85,812,836  
Granted (shares) 1,000,000    
Forfeited (shares) (7,961,710) (450,000)  
Outstanding, Ending Balance (shares) 78,401,126.000 85,362,836.000 85,812,836
Unvested shares expected to vest (shares) 48,574,548    
Exercisable (shares) 29,826,578    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted average exercise price per share, outstanding, beginning balance (in dollars per share) $ 1.19 $ 1.19  
Weighted average exercise price per share, forfeited (in dollars per share) 1.32 1.93  
Weighted average exercise price per share, outstanding, ending balance (in dollars per share) 1.18 $ 1.19 $ 1.19
Weighted average exercise price per share, unvested shares expected to vest (in dollars per share) 1.21    
Weighted average exercise price per share, Exercisable (in dollars per share) $ 1.13    
Outstanding, weighted average remaining contractual life 5 years 3 months 12 days 5 years 9 months 23 days 5 years 9 months 23 days
Unvested shares expected to vest, weighted average remaining contractual life 5 years 4 months 16 days    
Exercisable at end of period, weighted average remaining contractual life 5 years 1 month 12 days    
Outstanding, aggregate intrinsic value $ 51.2 $ 0.0 $ 0.0
Unvested shares expected to vest, aggregate intrinsic value 30.5    
Exercisable, aggregate intrinsic value $ 20.7